Investors Become Goldilocks in a Bear Market

Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.

Speakers:

• Bill Newell, Sutro Biopharma
• Dr. Lisa Drakeman, Biotech Entrepreneur
• Sougato Das, PRISM.science